部分胸骨切开与全胸骨切开行升主动脉及主动脉瓣上段置换的比较
该研究比较了部分上段胸骨切开(PS)与全胸骨切开(FS)行主动脉瓣置换(AVR)联合升主动脉管状部主动脉瓣上段置换的疗效。纳入2000—2015年652例择期患者,经2:1倾向评分匹配后PS组117例、FS组234例。结果显示两组体外循环时间、主动脉阻断时间、术后并发症、院内死亡及中期生存均无显著差异。
要点
- PS与FS行AVR联合升主动脉瓣上段置换的术后并发症和院内死亡无显著差异。
- 两组体外循环时间89 vs 92 min(P=0.3)、主动脉阻断时间65 vs 70 min(P=0.2)无显著差异。
- PS组院内死亡率1.7% vs FS组0.4%(P=0.3),中期生存无差异(P=0.3)。
核心结论
- 在高容量且微创心脏手术经验丰富的中心,PS行AVR联合升主动脉瓣上段置换的安全性和远期效果与FS相似。
研究设计与样本
- 单中心回顾性队列研究,纳入2000—2015年择期AVR联合升主动脉瓣上段置换患者652例,排除急诊、其他重大合并手术及再次手术。
- 经2:1倾向评分匹配后比较PS组117例与FS组234例的结局。
主要发现
- PS组与FS组体外循环时间分别为89 min与92 min(P=0.2),主动脉阻断时间分别为65 min与70 min(P=0.3)。
- 术后并发症发生率低,两组术后结局无显著差异。
- 院内死亡率PS组1.7%、FS组0.4%(P=0.3);Kaplan-Meier分析中期生存无差异(P=0.3)。
- 因瓣膜或主动脉并发症再次手术率极低,两组无显著差异。
关键数值与推荐
- PS组与FS组体外循环时间89 vs 92 min(P=0.2),主动脉阻断时间65 vs 70 min(P=0.3)。
- 院内死亡率PS组1.7% vs FS组0.4%(P=0.3)。
- 中期生存Kaplan-Meier分析P=0.3。
临床怎么用
- 在高容量微创心脏手术中心,PS可作为AVR联合升主动脉瓣上段置换的替代入路,安全性和远期效果与FS相当。
局限性
- 单中心回顾性研究,结果可能受中心经验和选择偏倚影响。
- 排除急诊、其他重大合并手术及再次手术患者,结论适用范围有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Full sternotomy (FS) is the common surgical access for patients undergoing open aortic valve replacement (AVR) with concomitant supracommissural replacement of the tubular ascending aorta. Since minimally invasive approaches are being used with increasing frequency in cardiac surgery, the aim of this study was to compare outcomes of patients undergoing AVR with supracommissural replacement of the tubular ascending aorta via FS versus partial upper sternotomy (PS). METHODS: We included all patients who underwent elective AVR with concomitant supracommissural replacement of the tubular ascending aorta at our institution between 2000 and 2015. Exclusion criteria were emergency surgery, other major concomitant procedures and reoperations. After 2:1 propensity score matching, outcomes of patients with PS and FS were compared. RESULTS: A total of 652 consecutive patients were included, 117 patients operated via PS and 234 patients operated via FS. Cardiopulmonary bypass time and aortic cross-clamp time of the PS and FS groups were 89 vs 92 min (P = 0.2) and 65 vs 70 min (P = 0.3), respectively. Postoperative morbidity was low and there were no significant differences in postoperative outcomes between patient groups. In-hospital mortality was 1.7% in the PS vs 0.4% in the FS group (P = 0.3). Kaplan-Meier analysis revealed no difference in mid-term survival (P = 0.3). Reoperation rates for valve or aortic complications were very low with no significant difference between groups. CONCLUSIONS: In a high-volume centre with extensive experience in minimally invasive cardiac surgery, AVR with concomitant supracommissural replacement of the tubular ascending aorta via PS results in similar outcomes with regard to safety and longevity when compared to conventional FS.
引用
- Haunschild J, van Kampen A, von Aspern K, et al. Supracommissural replacement of the ascending aorta and the aortic valve via partial versus full sternotomy-a propensity-matched comparison in a high-volume centre. Eur J Cardiothorac Surg. 2022. PMID: 34453828. doi:10.1093/ejcts/ezab373
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。